Our Motley Fool contributors think now could be the perfect time for biotech investors to add Spark Therapeutics (NASDAQ:ONCE), Esperion Therapeutics (NASDAQ:ESPR), and Celgene Corp. (NASDAQ:CELG) to portfolios. Why? An overreaction to trial data could mean Spark's shares are on sale, Esperion Therapeutics has big news fast approaching, and Celgene may be one of biotech's best bargain-bin buys.
Here's why these biotech stocks may be right for you.
Perfection is the enemy of the good enoughChuck Saletta (Spark Therapeutics): Spark Therapeutics recently saw its shares take a nose dive on news that its candidate for hemophilia A treatment worked but not flawlessly. Patients involved in its clinical trial saw a substantial reduction in the bleeding associated with hemophilia, but there was one serious adverse reaction to the treatment that resulted in hospitalization.
IMAGE SOURCE: GETTY IMAGES.
Top Biotech Stocks To Own For 2019: Freeport-McMoran, Inc.(FCX)
Advisors' Opinion:- [By Todd Campbell]
If these reasons have you interested in adding gold mining stocks to your portfolio, a few top companies to consider are Barrick Gold (NYSE:ABX), Randgold Resources (NASDAQ:GOLD), Newmont Mining (NYSE:NEM), Freeport McMoran (NYSE:FCX) and Goldcorp (NYSE:GG). All five could benefit if gold prices rally, so let's learn more about them.
- [By ]
Major turning points like the one we're seeing right now can generate spectacular comeback moves. In fact, we're already witnessing several of these rallies in our commodity-centric plays. Just look at copper miner Freeport-McMoRan Inc. (NYSE: FCX).
- [By Lisa Levin] Companies Reporting Before The Bell United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion. The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion. Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion. Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion. Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion. The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion. Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion. 3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion. JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion. Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion. Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion. Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion. Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion. The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion. Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion. PACCAR Inc (NASDAQ: PCAR) is projected to
- [By Jon C. Ogg]
Freeport-McMoRan Inc. (NYSE: FCX) was raised to Overweight from Equal Weight at Morgan Stanley, but the firm lowered its price target to $14 from $16.
- [By Paul Ausick]
Freeport-McMoRan Inc. (NYSE: FCX) traded down about 3.8% Friday to set a new 52-week low of $13.05 after closing at $113.57 on Thursday. The stock’s 52-week high is $20.25. Volume was about 15% higher than the daily average of around 16.8 million. The company had no specific news.
- [By Joseph Griffin]
Freeport-McMoRan (NYSE:FCX)‘s stock had its “sell” rating reissued by analysts at Berenberg Bank in a research note issued to investors on Wednesday. They presently have a $15.00 target price on the natural resource company’s stock. Berenberg Bank’s price target would suggest a potential downside of 13.54% from the company’s previous close.
Top Biotech Stocks To Own For 2019: Monotype Imaging Holdings Inc.(TYPE)
Advisors' Opinion:- [By Logan Wallace]
Typerium (CURRENCY:TYPE) traded 3% lower against the US dollar during the 1 day period ending at 16:00 PM Eastern on February 6th. One Typerium token can currently be bought for approximately $0.0006 or 0.00000018 BTC on major cryptocurrency exchanges including LATOKEN, Trade Satoshi and CoinExchange. Over the last week, Typerium has traded 21.7% higher against the US dollar. Typerium has a total market capitalization of $57,090.00 and $628.00 worth of Typerium was traded on exchanges in the last day.
- [By Joseph Griffin]
Monotype Imaging (NASDAQ:TYPE) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Monotype Imaging (TYPE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top Biotech Stocks To Own For 2019: Dynamic Materials Corporation(BOOM)
Advisors' Opinion:- [By Lisa Levin]
DMC Global Inc. (NASDAQ: BOOM) shares shot up 25 percent to $39.55 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
Shares of Knowles Corporation (NYSE: KN) got a boost, shooting up 15 percent to $12.83 as the company reported Q1 results.
- [By Stephan Byrd]
Hunter Associates Investment Management LLC decreased its position in Dmc Global Inc (NASDAQ:BOOM) by 2.4% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 331,609 shares of the industrial products company’s stock after selling 8,075 shares during the period. Dmc Global makes up approximately 5.4% of Hunter Associates Investment Management LLC’s holdings, making the stock its biggest position. Hunter Associates Investment Management LLC’s holdings in Dmc Global were worth $14,889,000 at the end of the most recent reporting period.
- [By Lisa Levin]
DMC Global Inc. (NASDAQ: BOOM) shares shot up 26 percent to $39.85 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
Shares of eHealth, Inc. (NASDAQ: EHTH) got a boost, shooting up 19 percent to $19.04 as the company posted upbeat Q1 results.
No comments:
Post a Comment